Skip to main content
Clinical Trials/NCT04602832
NCT04602832UnknownNot Applicable

A Randomized Controlled Trial of an Online Well-Being Intervention (The ENHANCE Program) for Improving Individuals Health and Well-Being During the COVID-19 Pandemic

University of British Columbia1 site in 1 country350 target enrollmentStarted: October 14, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
350
Locations
1
Primary Endpoint
Perceived Stress Scale (PSS)

Study Overview

Brief Summary

This study is a randomized controlled trial of an online, evidenced-based intervention (the ENHANCE program) that was modified to address the health and well-being challenges of COVID-19. Eligible participants will be randomized into the ENHANCE or Wait-List Control group over a 12-week period. ENHANCE participants will be introduced, and asked to practice, 10 evidenced-based principles and skills of happiness and well-being. Participants will complete an online survey about their health and well-being at baseline, midway (or 6 weeks), post-assessment (or at the end of the 12-week study), and 3-months following the end of the study.

Detailed Description

The study is designed as a 12-week, two-armed, randomized controlled trail to assess the efficacy of a COVID-19-modified version of the Enduring Happiness and Continued Self-Enhancement (ENHANCE) program. The ENHANCE program represents a 12-week multi-construct, evidenced-based intervention for improving overall happiness and subjective well-being. The ENHANCE program was modified specifically to address the known health and well-being challenges of the COVID-19 pandemic.

Eligible participants will be randomized into either the ENHANCE program or Wait-List Control (WLC) group. ENHANCE participants will be introduced to 10 evidenced-based principles that have been shown to improve health and well-being outcomes. Participants will be further guided to systematically practice these principles in their daily lives using a small-changes approach. WLC participants will be asked to continue life a usual, and provided some additional health and well-being resources that can be accessed online to support current, ongoing distress, if needed.

Participants will be asked to complete an online survey about their emotional, social, and physical well-being at baseline (or at the start of the study), midway (or 6-weeks into the study), and at post-assessment (or at the end of the study period). At the end of the study period, all control participants will also be offered the full ENHANCE program.

Investigators expect that participants receiving the ENHANCE program will show improvements across all negative (e.g., depression, anxiety) and positive (e.g., life satisfaction, quality of life) variables from baseline to post-study. Investigators further expect there to be immediate positive health and economic outcomes linked to active participation in the ENHANCE program (versus the WLC group). Investigators believe the impacts of this research will include (a) mitigating the risk of a severe onset of mental health problems related to anxiety, depression, post-traumatic stress, and suicide, (b) increasing positive mental health and well-being, and (c) increasing physical health in participants across time.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Individuals who are fluent in English and are 19 years or older.

Exclusion Criteria

  • Not provided

Arms & Interventions

ENHANCE Treatment Group

Experimental

The ENHANCE program was tailored to address the current health and well-being challenges faced by individuals living in the COVID-19 pandemic. The contents of each week will focus on a new evidenced-based principle that has been shown in research to decrease negative thinking and emotions, as well as increase positive thinking, emotions, and overall physical and mental health and well-being. Each week participants will focus on the skills and methods of implementing happiness and well-being into their daily routine.

Intervention: Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19 (Other)

Wait-List Control Group

No Intervention

Over the course of the study, participants will be asked to refrain from accessing the ENHANCE program materials to ensure the integrity of the research design. At the end of the study duration, participants will receive the full ENHANCE program.

Outcomes

Primary Outcomes

Perceived Stress Scale (PSS)

Time Frame: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)

Change from baseline stress

Generalized Anxiety Disorder - 7 (GAD-7)

Time Frame: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)

Change from baseline anxiety

Beck Depression Inventory - II (BDI-II)

Time Frame: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)

Change from baseline mood

Patient Health Questionnaire (PHQ-9)

Time Frame: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)

Change from baseline mood

Positive and Negative Affect Scale (PANAS)

Time Frame: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)

Change from baseline affect

Health Anxiety Inventory Short-Form (HAI-SF)

Time Frame: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)

Change from baseline anxiety

Satisfaction With Life Scale (SWLS)

Time Frame: Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months)

Change from baseline satisfaction with life

Secondary Outcomes

  • Sleep Disorder Questionnaire (SDQ)(Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months))
  • PTSD Checklist for the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (PCL-5)(Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months))
  • Meaning In Life Questionnaire (MLQ)(Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months))
  • Paffenbarger Physical Activity Questionnaire (PPAQ)(Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months))
  • University of California, Los Angeles Loneliness Scale (UCLA Loneliness Scale)(Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months))
  • European Quality of Life Group - 5 Dimensions - 5 Levels (EQ-5D-5L)(Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months))
  • World Health Organization Quality of Life (WHOQOL - BREF)(Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months))
  • Measure of Attachment Qualities (MAQ)(Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months))
  • Insomnia Severity Index (ISI)(Baseline, Mid-assessment (6 weeks), Post-assessment (3 months), Follow-up-assessment (6 months))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Lesley Lutes

Dr. Lesley Lutes, R.Psych.

University of British Columbia

Study Sites (1)

Loading locations...

Similar Trials